Cargando…
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is an Epstein Barr virus (EBV)-related malignancy in which the tumor microenvironment plays a pivotal role in tumor progression. Here, we developed two patient-derived xenograft (PDX) mouse lines from engrafted NPC metastatic tumors. Positive staining for EBV-encoded s...
Autores principales: | Hsu, Cheng-Lung, Kuo, Yung-Chia, Huang, Yenlin, Huang, Yin-Cheng, Lui, Kar-Wai, Chang, Kai-Ping, Lin, Tung-Liang, Fan, Hsien-Chi, Lin, An-Chi, Hsieh, Chia-Hsun, Lee, Li-Yu, Wang, Hung-Ming, Li, Hsin-Pai, Chang, Yu-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741608/ https://www.ncbi.nlm.nih.gov/pubmed/26416517 |
Ejemplares similares
-
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways
por: Li, Hsin-Pai, et al.
Publicado: (2023) -
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment
por: Li, Hsin-Pai, et al.
Publicado: (2021) -
Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis
por: Wang, Hung-Ming, et al.
Publicado: (2016) -
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2018) -
Progesterone analogues reduce plasma Epstein–Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care
por: Hung, Chia-Yen, et al.
Publicado: (2017)